Literature DB >> 19692484

Deletion of the vitamin D receptor specifically in the parathyroid demonstrates a limited role for the receptor in parathyroid physiology.

Tomer Meir1, Ronen Levi, Liesbet Lieben, Steven Libutti, Geert Carmeliet, Roger Bouillon, Justin Silver, Tally Naveh-Many.   

Abstract

1,25(OH)2D3 decreases parathyroid hormone (PTH) gene transcription through the vitamin D receptor (VDR). Total body VDR(-/-) mice have high PTH levels, hypocalcemia, hypophosphatemia, and bone malformations. To investigate PTH regulation by the VDR specifically in the parathyroid, we generated parathyroid-specific VDR knockout mice (PT-VDR(-/-)). In both strains, there was a decrease in parathyroid calcium receptor (CaR) levels. The number of proliferating parathyroid cells was increased in the VDR(-/-) mice but not in the PT-VDR(-/-) mice. Serum PTH levels were moderately but significantly increased in the PT-VDR(-/-) mice with normal serum calcium levels. The sensitivity of the parathyroid glands of the PT-VDR(-/-) mice to calcium was intact as measured by serum PTH levels after changes in serum calcium. This indicates that the reduced CaR in the PT-VDR(-/-) mice enables a physiologic response to serum calcium. Serum C-terminal collagen crosslinks, a marker of bone resorption, were increased in the PT-VDR(-/-) mice with no change in the bone formation marker, serum osteocalcin, consistent with a resorptive effect due to the increased serum PTH levels in the PT-VDR(-/-) mice. Therefore, deletion of the VDR specifically in the parathyroid decreases parathyroid CaR expression and only moderately increases basal PTH levels, suggesting that the VDR has a limited role in parathyroid physiology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19692484     DOI: 10.1152/ajprenal.00360.2009

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  16 in total

1.  A kidney-specific genetic control module in mice governs endocrine regulation of the cytochrome P450 gene Cyp27b1 essential for vitamin D3 activation.

Authors:  Mark B Meyer; Nancy A Benkusky; Martin Kaufmann; Seong Min Lee; Melda Onal; Glenville Jones; J Wesley Pike
Journal:  J Biol Chem       Date:  2017-08-14       Impact factor: 5.157

2.  CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders.

Authors:  Xiuying Bai; Dengshun Miao; Sophia Xiao; Dinghong Qiu; René St-Arnaud; Martin Petkovich; Ajay Gupta; David Goltzman; Andrew C Karaplis
Journal:  J Clin Invest       Date:  2016-01-19       Impact factor: 14.808

Review 3.  Hyperparathyroid genes: sequences reveal answers and questions.

Authors:  Stephen J Marx
Journal:  Endocr Pract       Date:  2011 Jul-Aug       Impact factor: 3.443

Review 4.  Vitamin D3: a helpful immuno-modulator.

Authors:  Michelino Di Rosa; Michele Malaguarnera; Ferdinando Nicoletti; Lucia Malaguarnera
Journal:  Immunology       Date:  2011-10       Impact factor: 7.397

5.  Vitamin D status and outcomes after renal transplantation.

Authors:  Frank Bienaimé; Delphine Girard; Dany Anglicheau; Guillaume Canaud; Jean Claude Souberbielle; Henri Kreis; Laure Hélène Noël; Gérard Friedlander; Caroline Elie; Christophe Legendre; Dominique Prié
Journal:  J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 10.121

Review 6.  Physiological insights from the vitamin D receptor knockout mouse.

Authors:  Marie B Demay
Journal:  Calcif Tissue Int       Date:  2012-08-18       Impact factor: 4.333

7.  Compensatory Changes in Calcium Metabolism Accompany the Loss of Vitamin D Receptor (VDR) From the Distal Intestine and Kidney of Mice.

Authors:  Perla C Reyes-Fernandez; James C Fleet
Journal:  J Bone Miner Res       Date:  2015-08-20       Impact factor: 6.741

Review 8.  FGF-23 and secondary hyperparathyroidism in chronic kidney disease.

Authors:  Justin Silver; Tally Naveh-Many
Journal:  Nat Rev Nephrol       Date:  2013-07-23       Impact factor: 28.314

Review 9.  Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors.

Authors:  Jessica Costa-Guda; Andrew Arnold
Journal:  Mol Cell Endocrinol       Date:  2013-09-11       Impact factor: 4.102

10.  Parathyroid diseases and animal models.

Authors:  Yasuo Imanishi; Yuki Nagata; Masaaki Inaba
Journal:  Front Endocrinol (Lausanne)       Date:  2012-06-27       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.